null

Natalizumab Biosimilar (Anti-ITGA4) Antibody (HDBS0068)

SKU:
HDBS0068
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
ITGA4
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
$479
Frequently bought together:

Description

system_update_altDatasheet

Natalizumab (Anti-ITGA4) Biosimilar Antibody (HDBS0068)

The Anti-ITGA4 (Natalizumab Biosimilar) Antibody (HDBS0068) is a vital tool for research involving integrin alpha-4 (ITGA4), a cell surface protein involved in cell adhesion and migration processes. This antibody, produced through a biosimilar to Natalizumab, is highly specific and reactive with human samples, making it suitable for various applications such as immunohistochemistry, flow cytometry, and ELISA.ITGA4 is a key player in the immune system, mediating the adhesion of immune cells to the endothelium during inflammation and immune surveillance. Dysregulation of ITGA4 function has been linked to autoimmune diseases, inflammatory disorders, and cancer progression.

By targeting ITGA4 with the Anti-ITGA4 Antibody, researchers can further investigate the role of this protein in disease pathogenesis and potentially identify novel therapeutic strategies to modulate immune responses.In summary, the Anti-ITGA4 (Natalizumab Biosimilar) Antibody (HDBS0068) is a valuable research tool for studying ITGA4-mediated processes in immunology, inflammation, and cancer biology. Its high specificity and reactivity with human samples make it a reliable choice for researchers seeking to elucidate the role of ITGA4 in health and disease.